The Antiviral 2′,5′-Oligoadenylate Synthetase Is Persistently Activated in Type 1 Diabetes

Author： Bonnevie-Nielsen V. Martensen P.M. Justesen J. Kyvik K.O. Kristensen B. Levin K. Beck-Nielsen H. Worsaa A. Dyrberg T.

Publisher： Academic Press

ISSN： 1521-6616

Source： Clinical Immunology, Vol.96, Iss.1, 2000-07, pp. : 11-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Production of the antiviral proteins 2'5'oligoadenylate synthetase, PKR and Mx in interstitial cells and spermatogonia

By Melaine N. Lienard M.-O. Guillaume E. Ruffault A. Dejucq-Rainsford N. Jegou B.

Journal of Reproductive Immunology, Vol. 59, Iss. 1, 2003-06 ,pp. : 53-60

Elsevier

Access to resources Recommend Favorite

Immunotherapy of type 1 diabetes

By Li Li

Archivum Immunologiae et Therapiae Experimentalis, Vol. 56, Iss. 4, 2008-08 ,pp. : 227-236

Springer Publishing Company

Access to resources Recommend Favorite

A new drug for type 1 diabetes

By Ward S.

Trends in Immunology, Vol. 22, Iss. 11, 2001-11 ,pp. : 597-597

Elsevier

Access to resources Recommend Favorite

Immune Regulation in Type 1 Diabetes

By Shimada A. Charlton B. Rohane P. Taylor-Edwards C. Fathman G.C.

Journal of Autoimmunity, Vol. 9, Iss. 2, 1996-02 ,pp. : 263-269

Academic Press

Access to resources Recommend Favorite

The pancreas in human type 1 diabetes

By Rowe Patrick Campbell-Thompson Martha Schatz Desmond Atkinson Mark

Seminars in Immunopathology, Vol. 33, Iss. 1, 2011-01 ,pp. : 29-43

Springer Publishing Company

Access to resources Recommend Favorite